Pilar Catalán Rodríguez-rekin lankidetzan egindako argitalpenak (29)

2024

  1. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing

    International Journal of Medical Microbiology, Vol. 314

  2. Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2

    Frontiers in Immunology, Vol. 15

  3. No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir

    Journal of Medical Virology

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Alternative molecular and genomic strategies to provide a rapid response to alerts concerning the introduction of new emerging SARS-CoV-2 variants: the Omicron alert

    Microbiology Spectrum, Vol. 11, Núm. 5

  3. Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outbreak

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 194-200

  4. Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain

    Emerging infectious diseases, Vol. 29, Núm. 6, pp. 1154-1161

  5. Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab

    Antimicrobial agents and chemotherapy, Vol. 67, Núm. 7, pp. e0026623

  6. Rapid Identification of Relevant Microbial Strains by Identifying Multiple Marker Single Nucleotide Polymorphisms via Amplicon Sequencing: Epidemic Monkeypox Virus as a Proof of Concept

    Microbiology Spectrum, Vol. 11, Núm. 1

  7. Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved

    Genome medicine, Vol. 15, Núm. 1, pp. 57

2022

  1. Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

    Clinical Microbiology and Infection, Vol. 28, Núm. 6, pp. 865-870

  2. High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 288-292

  3. IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

  4. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

  5. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

    BMC infectious diseases, Vol. 22, Núm. 1, pp. 211

  6. SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid

    AIDS Research and Human Retroviruses, Vol. 38, Núm. 5, pp. 394-398

  7. Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain

    Emerging Infectious Diseases, Vol. 28, Núm. 1, pp. 85-94

  8. The relevance of multiple clinical specimens in the diagnosis of monkeypox virus, Spain, June 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 27, Núm. 33

2021

  1. Heart and liver transplant recipients from donor with positive SARS-CoV-2 RT-PCR at time of transplantation

    Transplant Infectious Disease

  2. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2

    Journal of Clinical Microbiology, Vol. 59, Núm. 2